Active NCI RFAs:  FY 2023  FY 2022  FY 2021  FY 2020 | Archive RFAs | Active PAs
Current and Recent Requests for Applications (RFA's)
RFA's that are active or have expired within the last 3 months (and associated notices)
 
2023 Trans-NIH Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
HL23-007 Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)ACTIVE - JAN 11, 2025
HL23-006 Stimulating Access to Research in Residency (StARR) (R38)ACTIVE - MAY 17, 2024
 
 
 
 
2022 Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
CA22-025 SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)ACTIVE - AUG 06, 2022
CA22-024 Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)ACTIVE - NOV 18, 2022
CA22-023 Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)ACTIVE - NOV 18, 2022
CA22-022 Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)ACTIVE - NOV 18, 2022
CA22-021 Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)ACTIVE - NOV 18, 2022
CA22-020 Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)ACTIVE - JUN 18, 2022
CA22-017 Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)ACTIVE - AUG 23, 2022
CA22-016 Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)ACTIVE - SEP 28, 2022
CA22-015 Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional)ACTIVE - JUL 07, 2022
CA22-014 Data, Evaluation and Coordinating Center for: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) (U24 Clinical Trial Not Allowed)EXPIRED - MAR 29, 2022
CA22-013 PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed)ACTIVE - NOV 02, 2022
CA22-012 Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed)ACTIVE - NOV 02, 2022
CA22-011 U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional)EXPIRED - MAR 31, 2022
CA22-010 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)ACTIVE - SEP 23, 2022
CA22-009 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)ACTIVE - SEP 23, 2022
CA22-008 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)ACTIVE - SEP 23, 2022
CA22-007 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)ACTIVE - SEP 23, 2022
CA22-006 Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)ACTIVE - SEP 23, 2022
CA22-005 Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)ACTIVE - SEP 23, 2022
CA22-004 Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)ACTIVE - SEP 23, 2022
CA22-003 Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)ACTIVE - SEP 23, 2022
CA22-002 Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)ACTIVE - SEP 23, 2022
CA22-001 Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)ACTIVE - SEP 23, 2022
 
2022 Trans-NIH Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
DE22-011 HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed)EXPIRED - APR 01, 2022
MD22-008 Understanding and Addressing Misinformation among Populations that Experience Health Disparities (R01 - Clinical Trials Optional)ACTIVE - NOV 14, 2022
MH22-130 Integrating Mental Health Care into Health Care Systems in Low- and Middle-Income Countries (R01 Clinical Trial Optional)ACTIVE - AUG 05, 2022
NS22-052 HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)ACTIVE - OCT 11, 2023
NS22-050 HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)ACTIVE - FEB 24, 2023
NS22-045 HEAL Initiative: National K12 Clinical Pain Career Development Program (K12 Clinical Trial Not Allowed)EXPIRED - MAR 25, 2022
NS22-037 HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required)EXPIRED - MAR 23, 2022
NS22-034 HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)ACTIVE - DEC 07, 2024
NS22-021 HEAL Initiative: Human Pain-associated Genes and Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)ACTIVE - OCT 12, 2022
NS22-018 HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes and Cells (U19 Clinical Trial Not Allowed)ACTIVE - MAR 10, 2023
OD22-010 Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)ACTIVE - JUL 02, 2024
OD22-009 Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)ACTIVE - JUL 02, 2024
OD22-008 Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed)ACTIVE - JUL 02, 2024
OD22-007 INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)ACTIVE - JUL 02, 2024
OD22-006 Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)EXPIRED - MAY 03, 2022
OD22-005 Emergency Awards: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)EXPIRED - MAY 03, 2022
OD22-004 Tobacco Centers of Regulatory Science (TCORS) for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U54 Clinical Trial Optional)ACTIVE - JUL 15, 2022
OD22-002 Center for Rapid Surveillance of Tobacco (CRST) to Assess Changes in Use Behaviors, Product Marketing, and the Marketplace (U01 Clinical Trial Not Allowed)ACTIVE - MAY 19, 2022
TR22-013 Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)ACTIVE - MAY 23, 2023
TR22-011 Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed)ACTIVE - MAY 23, 2023
 
 
 
 
2021 Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
CA21-062 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)EXPIRED - MAR 01, 2022
CA21-061 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)EXPIRED - MAR 01, 2022
CA21-060 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)EXPIRED - MAR 01, 2022
CA21-048 Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed)ACTIVE - OCT 20, 2022
CA21-020 National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)ACTIVE - SEP 29, 2023
 
2021 Trans-NIH Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
HG21-001 Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed)ACTIVE - JUN 16, 2023
OD21-007 INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed)ACTIVE - NOV 04, 2022
OD21-004 Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)ACTIVE - MAR 09, 2023
OD21-003 Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)ACTIVE - MAR 09, 2023
OD21-002 Tobacco Regulatory Science (R01 Clinical Trial Optional)ACTIVE - FEB 15, 2023
 
 
 
 
2020 Trans-NIH Requests for Applications (RFA's)
RFA No. and TitleStatus - Expiration
NS20-011 HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)ACTIVE - SEP 09, 2022
NS20-010 HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)ACTIVE - SEP 09, 2022
NS20-009 HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)ACTIVE - SEP 09, 2022
NS20-008 HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)ACTIVE - SEP 09, 2022
OD20-011 Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required)ACTIVE - JUL 11, 2022
OD20-010 Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required)ACTIVE - JUL 11, 2022
OD20-009 Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)ACTIVE - JUL 11, 2022
OD20-008 Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)ACTIVE - JUL 11, 2022